NCT02647385View on ClinicalTrials.gov

Pain Control in Breast Surgery: Analgesia, Opioid Consumption and Inflammatory Response Evaluation

NAActive, not recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

December 31, 2024

Study Completion Date

February 28, 2026

Conditions
Breast CancerAnesthesia
Interventions
DRUG

Block with lidocaine for SAM and PEC I block

"Patients could be submitted to general anesthesia or general anesthesia associated with SAM and PEC I block with lidocaine before mastectomy.~Interventions: include pain assessment, inflammatory response and opioid consumption."

Trial Locations (1)

01308050

Hospital Sírio-Libanês, São Paulo

All Listed Sponsors
lead

Hospital Sirio-Libanes

OTHER

NCT02647385 - Pain Control in Breast Surgery: Analgesia, Opioid Consumption and Inflammatory Response Evaluation | Biotech Hunter | Biotech Hunter